EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Drug-Related Pyroglutamic Acidosis: Systematic Literature Review

Tessa Scafetta, Orsolya Kovacs, Gregorio P Milani iD, Gabriel Bronz iD, Sebastiano A G Lava iD, Céline Betti, Federica Vanoni, Mario G Bianchetti, Pietro B Faré, Pietro Camozzi

Journal of Clinical Medicine · 27.09.2024 · 13 (19) · 5781

DOI: 10.3390/jcm13195781 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Journal of Clinical Medicine, online erschienen am 27.09.2024. Verfasst von Tessa Scafetta und 9 weiteren Autor:innen. Beteiligte Einrichtung: Family Medicine Institue, Faculty of Biomedical Sciences, Università della Svizzera Italiana, 6900 Lugano, Switzerland. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 144 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian ministry of health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Inborn errors of glutathione metabolism may cause high anion gap metabolic acidosis due to pyroglutamic acid accumulation. Since 1988, cases of this acidosis have been reported in individuals without these defects.

Methods

Given the poorly characterized predisposing factors, presentation, management, and prognosis of acquired pyroglutamic acidosis, we conducted a systematic review using the National Library of Medicine, Excerpta Medica, Web of Science, and Google Scholar databases.

Results

A total of 131 cases were found. Most patients were females (79%), adults (92%) aged 51 years or older (66%) with pre-existing conditions (74%) such as undernutrition, alcohol-use disorder, or kidney disease, and had an ongoing infection (69%). The clinical features included diminished consciousness (60%), Kussmaul breathing (56%), and nausea or vomiting (27%). At least 92% of patients were on paracetamol therapy for >10 days at an appropriate dose, 32% on a β-lactamase-resistant penicillin, and 2.3% on vigabatrin. Besides severe anion gap acidosis, patients also presented with hypokalemia (24%) and kidney function deterioration (41%). Management involved discontinuing the offending drug (100%), bicarbonate (63%), acetylcysteine (42%), and acute kidney replacement therapy (18%). The fatality rate was 18%, which was higher without acetylcysteine (24%) compared to with it (11%).

Conclusions

Acquired pyroglutamic acidosis is a rare, potentially fatal metabolic derangement, which usually occurs after paracetamol use, frequently combined with a β-lactamase-resistant penicillin or vigabatrin. This condition predominantly affects adults, especially women with factors like undernutrition, alcohol-use disorder, or kidney disease, often during infection. Increased awareness of this rare condition is necessary.

Schlagwörter

Stichwörter der Autor:innen

5-oxoprolineacetaminophenacid base equilibriumdrug-related side effectvigabatrinβ-lactamase-resistant penicillin

Autor:innen und Institutionen

  • Family Medicine Institue, Faculty of Biomedical Sciences, Università della Svizzera Italiana, 6900 Lugano, Switzerland.
  • Department of Anesthesia, Hôpital du Valais, 1951 Sion, Switzerland.
  • Pediatric Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
  • Department of Clinical Sciences and Community Health, Università degli Studi di Milano, 20122 Milan, Italy.
  • Pediatric Cardiology Unit, Department of Pediatrics, Centre Hospitalier Universitaire Vaudois, University of Lausanne, 1011 Lausanne, Switzerland.
  • Clinical Pharmacology Service, Centre Hospitalier Universitaire Vaudois, University of Lausanne, 1011 Lausanne, Switzerland.

ORCID-Profile: Gregorio P Milani, Gabriel Bronz, Sebastiano A G Lava

Förderung

  • Italian ministry of health

Zitieren

APA

Scafetta, T., Kovacs, O., Milani, G. P., Bronz, G., Lava, S. A. G., Betti, C., Vanoni, F., Bianchetti, M. G., Faré, P. B., & Camozzi, P. (2024). Drug-Related Pyroglutamic Acidosis: Systematic Literature Review. Journal of Clinical Medicine, 13(19), 5781. https://doi.org/10.3390/jcm13195781

Vancouver

Scafetta T, Kovacs O, Milani GP, Bronz G, Lava SAG, Betti C, et al. Drug-Related Pyroglutamic Acidosis: Systematic Literature Review. Journal of Clinical Medicine. 2024;13(19):5781. doi:10.3390/jcm13195781

BibTeX
@article{Scafetta2024,
  author = {Scafetta, Tessa and Kovacs, Orsolya and Milani, Gregorio P and Bronz, Gabriel and Lava, Sebastiano A G and Betti, Céline and Vanoni, Federica and Bianchetti, Mario G and Faré, Pietro B and Camozzi, Pietro},
  title = {Drug-Related Pyroglutamic Acidosis: Systematic Literature Review},
  journal = {Journal of Clinical Medicine},
  year = {2024},
  volume = {13},
  number = {19},
  pages = {5781},
  doi = {10.3390/jcm13195781}
}
Kostenlos starten →